Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2022-05-18 AGM Information
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Uzupełnione ogłoszenie o zwołaniu ZWZ BioMaxima S.A. wraz z projektami uchwał - Content (PL)
AGM Information Classification · 95% confidence The document text is very short (122 characters) and states that the Management Board of BioMaxima S.A. is providing a supplemented announcement regarding the convening of an Extraordinary General Meeting (ZWZ) along with draft resolutions. The mention of 'ZWZ' (Nadzwyczajne Walne Zgromadzenie - Extraordinary General Meeting) and associated resolutions strongly suggests materials related to a shareholder meeting, which aligns best with the scope of AGM-R (AGM Information) or potentially PSI (Proxy Solicitation & Information Statement) if it were soliciting votes. Since it is an announcement about convening the meeting and providing draft resolutions, it is most closely related to the materials presented at or for a general meeting. Given the options, AGM-R covers general meeting materials, and while ZWZ is extraordinary, the core function is similar to an AGM. However, since it is an announcement about convening the meeting and providing draft resolutions, it is a specific type of regulatory announcement related to shareholder meetings. Given the options, AGM-R is the closest fit for materials related to a General Meeting, even if extraordinary. If the document were soliciting proxies, PSI would be better, but this is an announcement of the meeting and resolutions.
2022-05-18 Polish
Sprawozdanie_Rady_Nadzorczej_BioMaxima_S.A._za_2021_r_.pdf
Audit Report / Information Classification · 98% confidence The document is titled "Sprawozdanie Rady Nadzorczej BioMaxima S.A. za rok obrotowy 2021" (Report of the Supervisory Board of BioMaxima S.A. for the financial year 2021). It details the activities of the Supervisory Board, the Audit Committee, the assessment of the financial statements (both individual and consolidated) for 2021, and governance practices (including deviations from 'Dobre Praktyki Spółek Notowanych na GPW 2021'). This content strongly aligns with the requirements for an Audit Report / Information document, which covers supervisory board oversight, audit assessments, and internal control reviews, especially when it is a standalone report focusing on these aspects rather than the full Annual Report (10-K) or just an earnings release (ER). While it contains elements reviewed in an Annual Report (like financial statement assessment), the focus is specifically on the Supervisory Board's oversight and audit review, making 'AR' (Audit Report / Information) the most precise fit among the provided options, as it explicitly covers 'applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)' and supervisory board reports. It is a comprehensive report itself, not an announcement of a report (ruling 2 does not apply). FY 2021
2022-05-16 Polish
Polityka_wynagrodzen_projekt.pdf
Remuneration Information Classification · 98% confidence The document is titled "POLITYKA WYNAGRODZEŃ Członków Zarządu i Rady Nadzorczej BioMaxima S.A." (Remuneration Policy for Members of the Management Board and Supervisory Board of BioMaxima S.A.). It details the objectives, contractual terms, fixed and variable remuneration components, and stock-based compensation for both the Management Board and the Supervisory Board members. This content directly corresponds to the definition of a Remuneration Information document, which is classified as DEF 14A in the provided schema, even though the document is in Polish and references Polish law. The content is a policy document, not a mere announcement of a report (RPA/RNS) or a general regulatory filing (RNS).
2022-05-16 Polish
Ogloszenie_ZWZ_BioMaxima_S.A._na_13.06.2022_i_projekty_uchwal.pdf
AGM Information Classification · 99% confidence The document is explicitly titled "Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Akcjonariuszy BioMaxima Spółka Akcyjna" (Announcement of the convening of the Annual General Meeting of Shareholders of BioMaxima S.A.). It details the date (June 13, 2022), agenda items typical for an AGM (approval of 2021 reports, granting discharge/absolutorium to management/supervisory board, profit distribution), and shareholder rights related to the meeting. This content directly corresponds to the definition of AGM Information. Although it contains resolutions (Uchwały) that might be part of a final report, the primary purpose and framing of the document is the convening notice and the proposed resolutions for the AGM, making AGM-R the most appropriate classification over a general Regulatory Filing (RNS) or a final voting result document (DVA).
2022-05-16 Polish
Ogłoszenie o zwołaniu ZWZ BioMaxima S.A. wraz z projektami uchwał - Content (PL)
AGM Information Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of BioMaxima S.A. is announcing ('przekazuje do publicznej wiadomości') the convening of the Ordinary General Meeting ('Zwyczajnego Walnego Zgromadzenia') along with draft resolutions ('projektami uchwał'). This content directly relates to the materials prepared for and announced regarding the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is very short, but the content is specific to the AGM event itself, not just an announcement that a report is available.
2022-05-16 Polish
Zwiększenie wartości znaczącej umowy - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is very short (790 characters) and describes the signing of an additional agreement for the sale, delivery, and installation of a cell culture analyzer. It references a previous report (ESPI nr 25/2022) concerning the main contract. This announcement details a specific business transaction (sale of equipment) that impacts future revenues, but it is not a full financial report (like 10-K or IR), nor is it a management change (MANG) or dividend notice (DIV). It is a specific operational update related to contracts and sales. Given the options, this type of specific business contract update that is not explicitly covered by other categories (like M&A, Financing, or Director's Dealing) fits best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements, or potentially 'Capital/Financing Update' (CAP) if interpreted broadly as a revenue-generating contract, but RNS is safer for specific operational news not fitting elsewhere. Since it is a specific contract signing, and not a general announcement about a report, RNS is the most appropriate general regulatory filing category.
2022-05-16 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.